Approval · Notice of Compliance 9417 · 2008
VALCYTE: Notice of Compliance 9417
Issued March 7, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9417
- Date
- March 7, 2008
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALCYTE | 02306085 | Marketed |
Medicinal ingredients
- VALGANCICLOVIR HYDROCHLORIDE 50 MG per ML